Financhill
Back

uniQure NV 10K Form

Sell
33

QURE
uniQure NV

Last Price:
18.86
Seasonality Move:
17.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive QURE News And Ratings

See the #1 stock for the next 7 days that we like better than QURE

QURE Financial Statistics

Sales & Book Value

Annual Sales: $524M
Cash Flow: $-20.26M
Price / Cash Flow: 0
Annual Sales: $10.42
Price / Book: 1.81

Profitability

EPS (TTM): -2.46000
Net Income (TTM): $-114.06M
Gross Margin: $499.03M
Return on Equity: -19.99%
Return on Assets: -14.91%

uniQure NV Earnings Forecast

Key uniQure NV Financial Ratios

  • The Gross Profit Margin over the past 9 years for QURE is 95.23%.
  • The Selling, General & Administrative Expenses for QURE have been equal to 10.74% of Gross Profit Margin.
  • The Research & Development expenses have been 27.40% of Revenue.
  • The Interest Expense is 2.27% of Operating Income.
  • The Net Earning history of QURE is 62.90% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

uniQure NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: QURE
CUSIP: N90064
Website: uniqure.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 10.84
Quick Ratio: 10.44

Price-to-Earnings

Trailing P/E Ratio: 2.68
Forward P/E Ratio: 0

QURE Technical Analysis vs Fundamental Analysis

Sell
33
uniQure NV (QURE) is a Sell

Is uniQure NV a Buy or a Sell?

  • uniQure NV stock is rated a Sell
    The current uniQure NV [QURE] share price is $18.86. The Score for QURE is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.